192 results on '"Sparling, David"'
Search Results
2. Real-Time Continuous Glucose Monitoring Reduced Costly Diabetes-Related Events in Adolescents and Young Adults despite Lack of Short-Term Reduction in Hemoglobin A1c
3. Rol-Land Farms: Passing the Mantle
4. Degradation of the Nuclear Matrix Is a Common Element during Radiation-Induced Apoptosis and Necrosis
5. Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity
6. Greening Manufacturing Supply Chains – Introducing Bio-based Products into Manufacturing Supply Chains
7. Regulation and the financial performance of Canadian agribusinesses
8. Australian Biotechnology IPOs: Too Early, Too Small?
9. Simulations and supply chains: strategies for teaching supply chain management
10. Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry
11. Hyperphosphorylation of MEF2A in primary adipocytes correlates with downregulation of human GLUT4 gene promoter activity
12. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase
13. A Framework for Translating Biotechnology Experiences to Nanotechnology
14. 111-OR: MODY3 Diagnosis from Deidentified Pancreatic Tissue Leads to Variant Identification in Living Relatives
15. Inhibition of γ-secretase in adipocytes leads to altered IL-6 secretion and adipose inflammation
16. Novel role for an HPt domain in stabilizing the phosphorylated state of a response regulator domain
17. Weight Loss Results in Increased Expression of Anti‐Inflammatory Protein CRISPLD2 in Mouse Adipose Tissue
18. Firm, market, and regulatory factors influencing innovation and commercialization in Canada's functional food and nutraceutical sector
19. Strategic Alliances in the Canadian Biotechnology Sector
20. Further thoughts on the relationship between economic valued added and stock market performance
21. An assessment of the strategies and strengths of medium-sized food processors
22. Macrophage‐Derived microRNA‐155 Increases in Obesity and Influences Adipocyte Metabolism by Targeting Peroxisome Proliferator‐Activated Receptor Gamma
23. 1277-P: Diabetes Management Supplies in Youth with Type 1 Diabetes: Don’t Leave Home Without Them!
24. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study
25. Managing and reducing total cycle time: models and analysis
26. TML Foods Inc.
27. Murgo Farms Inc.: HACCP, ISO 9000, and ISO 14000
28. Essex Continental Distributors Inc.
29. Adipocyte Gamma-Secretase Inhibition May Alter IL-6 Expression and Trafficking
30. Factors affecting biotechnology innovation in Canada: analysis of the 2001 biotechnology use and development survey
31. Substitutes versus Complements among Canadian Business Risk Management Programs
32. mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2
33. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase
34. Farm Support Payments and Risk Balancing: Implications for Financial Riskiness of Canadian Farms
35. A Comment on "Peer Review in Ambulatory Care"
36. Canada’s shrinking Bioproduct Industry
37. Identifying successful business models, strategies and policies for promoting the Canadian Bioeconomy
38. Competitiveness of Canadian Agri-Food Supply Chains - Policy Brief
39. Innovation and Competitiveness - A Policy Brief
40. Policy, Industry Strategy and Healthy Food Innovation
41. Innovation and Bioproduct Development
42. North American Retailers and Their Impact on Food Chains
43. Bioproducts Development Survey: Analysis of the Summary Results
44. The Canadian Bioproducts Industry Analysis of the Bioproduct Development Survey - 2004
45. An Analysis of Financing Innovation and Commercialization in Canada's Functional Food and Nutraceutical Sector
46. Costs and Benefits of Traceability in the Canadian Dairy-Processing Industry
47. Traceability in the Canadian Dairy Processing Sector
48. HARMONIZING INTERNATIONAL AGREEMENTS WITH RESPECT TO INTEGRATED AGRICULTURAL MARKETS: BSE CASE STUDY (PowerPoint Presentation)
49. Factors Affecting Biotechnology Innovation in Canada: Analysis of the 2001 Biotechnology Use and Development Survey
50. Risk Management in the Integrated NAFTA Market: Lessons from the Case of BSE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.